Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Antiseptics for SARS-CoV-2 Viral Load
NCT05214196Phase 4Completed
- Sponsor
- Atatürk University
- Start
- Sep 2021
- Primary completion
- Dec 2021
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of hypochlorous acid in coronavirus disease 2019 (COVID-19), sponsored by Atatürk University. Started Sep 2021; status: completed.
02
Drugs
hypochlorous acid
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05214196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05214196.